Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before ... the use of an idle i.v. line for infusion whenever possible. In the prospective ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

Biogen and Eisai have announced that the US Food and Drug Administration (FDA) has accepted a Biologics License Application ...

is a brand-name intravenous (IV) infusion prescribed to treat COVID-19 in certain adults and children. As with other drugs, Veklury can cause side effects, such as nausea and increased liver enzymes.

About the Insignis Infusion System The Insignis Syringe Infusion System is a robust, non-electric device designed for routine ...

A prediction for 2025 by Marci Chodroff, M.D., vice president of Medical Affairs at Prime Therapeutics and Managed Healthcare ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...

By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...

This study aimed to evaluate the efficacy and safety of a method that optimizes background infusion (BI) alongside PCA for titrating intravenous (IV) morphine in managing cancer-related pain.